News for Thermo Fisher Scientific Inc. (TMO)

Delray Beach, FL, June 27, 2025 (GLOBE NEWSWIRE) -- The global laboratory information management system market, valued at US$2.54 billion in 2024, stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation of US$5.19 billion by the end of the period. The adoption of cloud-based LIMS is driven by the growing volume of laboratory data, growing pharmaceutical & biotechnology R&D expenditure, and the reduced total cost of ownership for informatics solutions. Factors such as automation, improved data accuracy, regulatory compliance, and efficient workflow management are fuelling this growth. Additionally, the integration of AI and machine learning in LIMS platforms enhances decision-making and predictive analytics. Cloud systems enable real-time data access, remote collaboration, and faster turnaround times, driving further innovation in the market. Growing emergence of low-code/low-code solutions and emerging markets such as China, India, Japan, Singapore, Brazil, and the Middle East present lucrative opportunities for growth.

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership aims to provide a fully integrated messenger ribonucleic acid (mRNA) solution to biopharmaceutical developers globally. The core objective of the collaboration is to accelerate the […]

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on D Invests’ Substack. In this article, we will summarize the bulls’ thesis on TMO. Thermo Fisher Scientific Inc. (TMO)’s share was trading at $408.53 as of 9th June. TMO’s trailing and forward P/E were 23.96 and 18.21 respectively according to Yahoo Finance. Thermo Fisher […]

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Even though Waters Corporation has outshined the industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

[url="]908 Devices Inc.[/url] (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D.

**media[651771]**

We came across a bullish thesis on Advance Auto Parts, Inc. (AAP) on Deep Value Capital’s Substack. In this article, we will summarize the bulls’ thesis on AAP. Advance Auto Parts, Inc. (AAP)’s share was trading at $51.68 as of 4th June. AAP’s trailing and forward P/E were 174.7 and 36.50 respectively according to Yahoo Finance. Advance […]

In the current market session, Thermo Fisher Scientific Inc. TMO price is at $401.51, after a 1.27% spike. However, over the past month, the stock fell by 1.35%...

Summary Thermo Fisher Scientific Inc (TMO), a global leader in scientific services, announced the launch of two groundbreaking mass spectrometers: the Thermo Sc

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientificâ„¢ Orbitrapâ„¢ Astralâ„¢ Zo

Thermo Fisher Scientific (TMO) has introduced two new mass spectrometers, the Thermo Scientific Orbitrap Astral Zoom and Orbitrap Excedion Pro. These cutting-ed

Thermo Fisher Scientific (TMO) unveils next-generation mass spectrometers at ASMS 2025, designed to advance biopharma applications and omics research. T

Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a Strong Buy.

Thermo Fisher and Lululemon trade far below highs. Zacks says now may be the time to buy these S&P 500 standouts for potential upside.

Thermo Fisher Scientific Inc. (TMO) has announced a strategic decision by its Board of Directors to grant a 5-year cliff vesting performance-based restricted

Summary Thermo Fisher Scientific Inc (TMO), a global leader in scientific services, has announced that its Board of Directors has authorized a quarterly cash di

In the current session, Thermo Fisher Scientific Inc. TMO is trading at $390.50, after a 3.83% drop. Over the past month, the stock fell by 8.66%, and in the pa...

**media[626353]**